Sanofi be­lieves it’s still not too late to be­come a top play­er in can­cer drug mar­ket

A lit­tle more than two years ago, Sanofi R&D chief Elias Zer­houni sig­naled the phar­ma gi­ant’s sore dis­ap­point­ment in its can­cer pipeline by ax­ing group …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.